<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38057014</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2405-4577</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Clinical nutrition ESPEN</Title><ISOAbbreviation>Clin Nutr ESPEN</ISOAbbreviation></Journal><ArticleTitle>Maximal oxidative capacity during exercise is associated with muscle power output in patients with long coronavirus disease 2019 (COVID-19) syndrome. A moderation analysis.</ArticleTitle><Pagination><StartPage>253</StartPage><EndPage>262</EndPage><MedlinePgn>253-262</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clnesp.2023.10.009</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2405-4577(23)02166-6</ELocationID><Abstract><AbstractText Label="BACKGROUND &amp; AIMS">Long COVID syndrome (LCS) involves persistent symptoms experienced by many patients after recovering from coronavirus disease 2019 (COVID-19). We aimed to assess skeletal muscle energy metabolism, which is closely related to substrate oxidation rates during exercise, in patients with LCS compared with healthy controls. We also examined whether muscle power output mediates the relationship between COVID-19 and skeletal muscle energy metabolism.</AbstractText><AbstractText Label="METHODS">In this cross-sectional study, we enrolled 71 patients with LCS and 63 healthy controls. We assessed clinical characteristics such as body composition, physical activity, and muscle strength. We used cardiopulmonary exercise testing to evaluate substrate oxidation rates during graded exercise. We performed statistical analyses to compare group characteristics and peak fat oxidation differences based on power output.</AbstractText><AbstractText Label="RESULTS">The two-way analysis of covariance (ANCOVA) results, adjusted for covariates, showed that the patients with LCS had lower absolute maximal fatty acid oxidation (MFO), relative MFO/fat free mass (FFM), absolute carbohydrates oxidation (CHox), relative CHox/FFM, and oxygen uptake (V&#x2d9;&#x2d9;O<sub>2</sub>) at maximum fat oxidation (g min<sup>-1</sup>) than the healthy controls (P&#xa0;&lt;&#xa0;0.05). Moderation analysis indicated that muscle power output significantly influenced the relationship between LCS and reduced peak fat oxidation (interaction &#x3b2;&#xa0;=&#xa0;-0.105 [95% confidence interval&#xa0;-0.174;&#xa0;-0.036]; P&#xa0;=&#xa0;0.026). Therefore, when muscle power output was below 388&#xa0;W, the effect of the LCS on MFO was significant (62% in our study sample P&#xa0;=&#xa0;0.010). These findings suggest compromised mitochondrial bioenergetics and muscle function, represented by lower peak fat oxidation rates, in the patients with LCS compared with the healthy controls.</AbstractText><AbstractText Label="CONCLUSION">The patients with LCS had lower peak fat oxidation during exercise compared with the healthy controls, potentially indicating impairment in skeletal muscle function. The relationship between peak fat oxidation and LCS appears to be mediated predominantly by muscle power output. Additional research should continue investigating LCS pathogenesis and the functional role of mitochondria.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ram&#xed;rez-V&#xe9;lez</LastName><ForeName>Robinson</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad P&#xfa;blica de Navarra (UPNA), Instituto de Investigaci&#xf3;n Sanitaria de Navarra (IdiSNA), Pamplona, Spain; CIBER of Frailty and Healthy Aging (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: robin640@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oscoz-Ochandorena</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad P&#xfa;blica de Navarra (UPNA), Instituto de Investigaci&#xf3;n Sanitaria de Navarra (IdiSNA), Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Alonso</LastName><ForeName>Yesenia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad P&#xfa;blica de Navarra (UPNA), Instituto de Investigaci&#xf3;n Sanitaria de Navarra (IdiSNA), Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Alonso</LastName><ForeName>Nora</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad P&#xfa;blica de Navarra (UPNA), Instituto de Investigaci&#xf3;n Sanitaria de Navarra (IdiSNA), Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Legarra-Gorgo&#xf1;on</LastName><ForeName>Gaizka</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad P&#xfa;blica de Navarra (UPNA), Instituto de Investigaci&#xf3;n Sanitaria de Navarra (IdiSNA), Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oteiza</LastName><ForeName>Julio</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna. Hospital Universitario de Navarra (HUN), Universidad P&#xfa;blica de Navarra (UPNA), Instituto de Investigaci&#xf3;n Sanitaria de Navarra (IdiSNA), Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorea</LastName><ForeName>Ander Ernaga</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Servicio de Endocrinolog&#xed;a y Nutricion. Hospital Universitario de Navarra (HUN), Universidad P&#xfa;blica de Navarra (UPNA), Instituto de Investigaci&#xf3;n Sanitaria de Navarra (IdiSNA), Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izquierdo</LastName><ForeName>Mikel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad P&#xfa;blica de Navarra (UPNA), Instituto de Investigaci&#xf3;n Sanitaria de Navarra (IdiSNA), Pamplona, Spain; CIBER of Frailty and Healthy Aging (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Correa-Rodr&#xed;guez</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nursing, Faculty of Health Sciences, University of Granada, 18016 Granada, Spain; Biosanitary Research Institute (ibs.GRANADA), Granada, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Nutr ESPEN</MedlineTA><NlmUniqueID>101654592</NlmUniqueID><ISSNLinking>2405-4577</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000273" MajorTopicYN="Y">Adipose Tissue</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Fatty acid oxidation</Keyword><Keyword MajorTopicYN="N">Muscle mass</Keyword><Keyword MajorTopicYN="N">Muscle strength</Keyword><Keyword MajorTopicYN="N">Post-acute COVID-19 syndrome</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>11</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>7</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>6</Day><Hour>20</Hour><Minute>59</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38057014</ArticleId><ArticleId IdType="doi">10.1016/j.clnesp.2023.10.009</ArticleId><ArticleId IdType="pii">S2405-4577(23)02166-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>